NEW YORK (GenomeWeb) – Luminex announced today that it has received CE-IVD marking for its Aries Flu A/B & RSV assay, clearing it for sale in Europe.

The assay runs on the Aries platform, a real-time PCR-based sample-to-answer system that detects and amplifies nucleic acids. It is designed to detect influenza A virus, influenza B virus, and respiratory syncytial virus nucleic acid from nasopharyngeal swabs specimens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.